home / stock / snwv / snwv news


SNWV News and Press, Sanuwave Health Inc

Stock Information

Company Name: Sanuwave Health Inc
Stock Symbol: SNWV
Market: OTC
Website: sanuwave.com

Menu

SNWV SNWV Quote SNWV Short SNWV News SNWV Articles SNWV Message Board
Get SNWV Alerts

News, Short Squeeze, Breakout and More Instantly...

SNWV - SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter 2024 (Ended June 30, 2024)

SANUWAVE is pleased to announce preliminary revenues of $7.0 million to $7.2 million for the second quarter ended June 30, 2024. This represents the highest quarterly revenues in company history. Q1 2024 revenue increased between 50% and 54% compared to Q2 2023. UltraMist revenues for Q2 2024...

SNWV - SANUWAVE Announces Termination of Merger Agreement With SEP Acquisition Corp.

Company to Pursue Alternate Plans for Capital Structure Improvement Including a Proposed Reverse Stock Split and a Note and Warrant Exchange Independent of a Merger Transaction EDEN PRAIRIE, MN - ( NewMediaWire ) - June 26, 2024 - SANUWAVE  Health, Inc. (the “Company”...

SNWV - SANUWAVE Provides Corporate Update

SANUWAVE pays off $6.3 million Celularity note and interest for $2.075 million  SEPA merger outside date to be extended to June 30, 2024 Combined entity has applied to list on Cboe BZX Exchange, Inc.    EDEN PRAIRIE, MN - ( NewMediaWire ) - June 04, 2024 - SANUWAVE...

SNWV - SANUWAVE Will Host a Conference Call on June 4, 2024 at 8:30 AM (ET) to Provide a Corporate Update

EDEN PRAIRIE, MN - ( NewMediaWire ) - June 03, 2024 - SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Tuesday, June 4, 2024, at 8:30 AM (ET) to provide a corp...

SNWV - SANUWAVE Announces Q1 FY2024 Financial Results

Q1 2024 revenues were $5.8 million, up 53% from Q1 2023 Q1 2024 gross margin was 73%, up 600bp from Q1 2023 Operating loss was $1.1 million for Q1 2024 compared to $2.0 million for Q1 2023 Company provides guidance for revenue growth of 45-55% for Q2 2024 versus Q2 2023 and reit...

SNWV - SANUWAVE Will Host a Conference Call on May 10, 2024 at 8:30 AM (ET) to Present Q1 Financial Results

EDEN PRAIRIE, MN - ( NewMediaWire ) - May 07, 2024 - SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 10, 2024, at 8:30 AM (ET) to present the Q1 2024 f...

SNWV - SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)

SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history. Q1 2024 revenue increased between 51% and 56% compared to Q1 2023. UltraMist revenues for Q1 2...

SNWV - SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer

Sorensen brings strong finance, forecasting, analysis, and capital markets experience as well as abilities in software, process automation, and human resources to SANUWAVE EDEN PRAIRIE, MN - ( NewMediaWire ) - April 01, 2024 - SANUWAVE Health, Inc.  (the "Company" or "SANUWAVE&#...

SNWV - SANUWAVE Health appoints Peter Sorensen as CFO

2024-04-01 16:05:01 ET More on SANUWAVE Health SANUWAVE Health Inc. (SNWV) Q4 2023 Earnings Call Transcript SEP Acquisition shareholders approve Sanuwave SPAC merger Sanuwave Health sees Q4 record revenue $6.6M-$6.8M, up 20% Y/Y Financial information for SANU...

SNWV - SANUWAVE Health Inc. (SNWV) Q4 2023 Earnings Call Transcript

2024-03-22 13:17:11 ET SANUWAVE Health Inc. (SNWV) Q4 2023 Results Conference Call March 22, 2024 8:30 AM ET Company Participants Morgan Frank - CEO & Chairman Toni Rinow - Chief Financial Officer Conference Call Participants Candace Laryea - MD Catas...

Next 10